Recursion Pharmaceuticals granted 7,952,836 RSU awards to 230 new employees, per Nasdaq rules, in connection with an acquisition.

Unusual Whales
2024.12.20 21:27
On December 19, 2024, Recursion Pharmaceuticals, Inc. based in Salt Lake City, Utah, disclosed that the Compensation Committee of its Board of Directors sanctioned the allocation of inducement restricted stock unit (RSU) awards. These awards encompass 7,952,836 shares of its class A common stock and were designated for 230 new employees. This action was taken under Recursion's 2024 Inducement Equity Incentive Plan. The RSUs were granted to new employees upon their commencement of employment with a subsidiary of Recursion as part of the company's acquisition of Exscientia plc. This move adhered to Nasdaq Listing Rule 5635(c)(4) regarding inducement grants.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.